9688124

Source:http://linkedlifedata.com/resource/pubmed/id/9688124

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0265110, umls-concept:C0600437, umls-concept:C1521801
pubmed:issue	2
pubmed:dateCreated	1998-8-18
pubmed:abstractText	Intrathecal bolus administration of (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)aminio]diazen++ +-1-ium-1,2-diolate (DETA/NO), a long half-life diazeniumdiolate-class nitric oxide (NO) donor, was evaluated for safety and efficacy in the treatment of delayed cerebral vasospasm in a canine model of subarachnoid hemorrhage (SAH).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/9688124-9950513
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0253357
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/1-hydroxy-2-oxo-3,3-bis(2-aminoethyl..., http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Triazenes, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0022-3085
pubmed:author	pubmed-author:BanerjeeAA, pubmed-author:DohanF CFCJr, pubmed-author:RobertsonJ TJT, pubmed-author:Soble-SmithJJ, pubmed-author:WhiteR PRP, pubmed-author:WolfE WEW
pubmed:issnType	Print
pubmed:volume	89
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	279-88
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9688124-Analysis of Variance, pubmed-meshheading:9688124-Animals, pubmed-meshheading:9688124-Basilar Artery, pubmed-meshheading:9688124-Blood Pressure, pubmed-meshheading:9688124-Brain, pubmed-meshheading:9688124-Central Venous Pressure, pubmed-meshheading:9688124-Cerebral Angiography, pubmed-meshheading:9688124-Cisterna Magna, pubmed-meshheading:9688124-Disease Models, Animal, pubmed-meshheading:9688124-Dogs, pubmed-meshheading:9688124-Dose-Response Relationship, Drug, pubmed-meshheading:9688124-Drug Carriers, pubmed-meshheading:9688124-Heart Rate, pubmed-meshheading:9688124-Image Processing, Computer-Assisted, pubmed-meshheading:9688124-Injections, Spinal, pubmed-meshheading:9688124-Intracranial Pressure, pubmed-meshheading:9688124-Ischemic Attack, Transient, pubmed-meshheading:9688124-Nitric Oxide, pubmed-meshheading:9688124-Random Allocation, pubmed-meshheading:9688124-Respiration, pubmed-meshheading:9688124-Safety, pubmed-meshheading:9688124-Subarachnoid Hemorrhage, pubmed-meshheading:9688124-Tachyphylaxis, pubmed-meshheading:9688124-Triazenes, pubmed-meshheading:9688124-Vasodilator Agents
pubmed:year	1998
pubmed:articleTitle	Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
pubmed:affiliation	Department of Neurosurgery, University of Tennessee Center for the Health Sciences, Memphis 38163, USA. ewolf@utmem1.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't